MedPath

Tai Wah Shanzha Plus Tablet

Registration Number: MAL21086071T

Approved
Approval ID

671c5a7c6aa4f562

Registration Number

MAL21086071T

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types7 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (7)

120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved
100 TabletsAvailable
Package Size: 100 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
300 TabletsAvailable
Package Size: 300 Tablets
Status: NPRA Approved
600 TabletsAvailable
Package Size: 600 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (7)

Lycium barbarumActive
Monograph: lycium barbarum
Crataegus pinnatifidaActive
Chrysanthemum indicumActive
Monograph: chrysanthemum indicum
Ligusticum chuanxiongActive
Monograph: ligusticum chuanxiong
Polygonum multiflorumActive
Monograph: polygonum multiflorum
Salvia miltiorrhizaActive
Pueraria lobataActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tai Wah Shanzha Plus Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform